Feasibility Lead

ICON plc•Blue Bell, TX

About The Position

At ICON Strategic Solutions, you will work in a sponsor-dedicated model, supported by ICON’s global expertise. As the world’s largest FSP organisation, with over 90 sponsor partnerships, we offer stability, career development and a collaborative environment where your work contributes to the development of treatments that benefit patients worldwide.

Requirements

  • Bachelor’s degree in life sciences, nursing, public health, or a related field.
  • 5+ years of clinical operations experience in biotech, pharma, or CRO, with extensive experience in country and site feasibility oversight
  • Demonstrated ownership of country selection and/or site selection recommendations for global studies, with the analytical work to support them.
  • Strong quantitative skills — comfortable building enrollment models and country scorecards in Excel and working with trial-landscape and real-world data platforms (e.g., Citeline/Informa, IQVIA, TriNetX, ClinicalTrials.gov, EU CTIS).
  • Working knowledge of ICH GCP, global regulatory and start-up requirements, and country-level submission and approval timelines.
  • Excellent written and verbal communication — able to turn ambiguous data into a clear, defensible recommendation for a senior audience.
  • Ability to manage multiple studies and shifting priorities in a fast-moving, lean organization

Nice To Haves

  • Therapeutic experience: Experience in Immunology highly preferred (dermatology, GI - nice to have)

Responsibilities

  • Country strategy and feasibility assessment
  • Lead country selection strategy developing data-driven recommendations on country mix, site allocation, and enrollment distribution
  • Oversee CRO completion of design and execution of feasibility assessments including protocol-specific feasibility questionnaires, competitive landscape and trial-density analyses, epidemiology and standard-of-care review, and regulatory and start-up timeline mapping by country.
  • Pressure-test enrollment assumptions by triangulating internal performance data, external intelligence sources, and direct site and investigator input.
  • Site identification and selection
  • Build and maintain a curated, indication-specific site and investigator landscape across North America, Europe, Asia-Pacific, and Latin America, including academic centers, specialty networks, and high-performing private practices.
  • Lead site identification and qualification, coordinating with CRO partners to run pre-study assessments and translating findings into transparent, criteria-based selection recommendations.
  • Track and manage site performance history — enrollment rates, data quality, inspection and audit history, screen-failure patterns, and startup cycle times — and feed that history into future selection decisions.
  • Data, intelligence, and reporting
  • Maintain feasibility metrics and enrollment
  • Present feasibility findings, trade-offs, and recommendations clearly— including where the data is thin and what assumption is carrying the risk.
  • Cross-functional and vendor partnership
  • Serve as the feasibility point of contact for assigned programs, partnering with study teams from concept through first-patient-in.
  • Manage feasibility and site intelligence vendors and CRO feasibility teams — setting scope, holding quality and timeline standards, and reviewing deliverables critically.
  • Partner with Patient Advocacy and Recruitment on patient-finding, referral pathway, and site-support strategies for indications where the eligible population is scarce or highly competed.

Benefits

  • Competitive base salary and performance related incentives
  • Health and wellbeing programmes including medical, dental, and vision coverage where applicable
  • Retirement and pension plans
  • Life assurance and disability coverage
  • Employee assistance programmes and wellbeing resources
  • Learning and development opportunities through structured training and career pathways
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service